Which has stronger valuation and earnings, VCT or SYNT?

Victrex has higher earnings, but lower revenue than Synthomer. Victrex is trading at a lower price-to-earnings ratio than Synthomer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Victrex £296.40M 1.86 £30.80M -£22.40 N/A Synthomer £1.74B 0.10 -£82.04M -£96.00 N/A

Is VCT or SYNT more profitable?

Victrex has a net margin of -6.70% compared to Synthomer's net margin of -9.03%. Victrex's return on equity of -4.95% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Victrex -6.70% -4.95% 6.59% Synthomer -9.03% -16.66% -0.28%

Do analysts rate SYNT or SCPA?

Synthomer currently has a consensus price target of GBX 86.75, indicating a potential downside of 21.85%. Given Scapa Group's higher probable upside, analysts clearly believe Scapa Group is more favorable than Synthomer. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synthomer 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings & valuation, ESNT or SYNT?

Essentra has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Essentra £302M 0.79 £3.50M £0.70 121.00 Synthomer £1.74B 0.10 -£82.04M -£96.00 N/A

Is ESNT or SYNT more profitable?

Essentra has a net margin of 0.70% compared to Synthomer's net margin of -9.03%. Essentra's return on equity of 0.79% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Essentra 0.70% 0.79% 1.74% Synthomer -9.03% -16.66% -0.28%

Which has higher valuation and earnings, ZTF or SYNT?

Zotefoams has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £158.49M 1.40 £9.80M £44.87 10.08 Synthomer £1.74B 0.10 -£82.04M -£96.00 N/A

Is ZTF or SYNT more profitable?

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -9.03%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 14.28% 18.25% 5.48% Synthomer -9.03% -16.66% -0.28%

Which has better valuation & earnings, SYNT or TET?

Treatt has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.74B 0.10 -£82.04M -£96.00 N/A Treatt £128.29M 1.39 £11.22M £7.22 41.83

Is SYNT or TET more profitable?

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -9.03%. Treatt's return on equity of 3.22% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -9.03% -16.66% -0.28% Treatt 3.40% 3.22% 6.72%

Synthomer (SYNT) Competitors

GBX 111 -4.00 (-3.48%)

As of 12:36 PM Eastern

Compare

SYNT vs. VCT, SCPA, ESNT, ZTF, and TET

Should you buy Synthomer stock or one of its competitors? MarketBeat compares Synthomer with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Synthomer include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Zotefoams (ZTF), and Treatt (TET). These companies are all part of the "specialty chemicals" industry.

How does Synthomer compare to Victrex?

Victrex (LON:VCT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

Victrex has higher earnings, but lower revenue than Synthomer. Victrex is trading at a lower price-to-earnings ratio than Synthomer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Victrex	£296.40M	1.86	£30.80M	-£22.40	N/A
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A

Victrex has a beta of 0.756, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Synthomer has a beta of 1.012, suggesting that its share price is 1% more volatile than the broader market.

Victrex has a net margin of -6.70% compared to Synthomer's net margin of -9.03%. Victrex's return on equity of -4.95% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Victrex	-6.70%	-4.95%	6.59%
Synthomer	-9.03%	-16.66%	-0.28%

In the previous week, Victrex had 2 more articles in the media than Synthomer. MarketBeat recorded 2 mentions for Victrex and 0 mentions for Synthomer. Synthomer's average media sentiment score of 0.76 beat Victrex's score of -0.50 indicating that Synthomer is being referred to more favorably in the news media.

Company	Overall Sentiment
Victrex	Negative
Synthomer	Positive

Victrex currently has a consensus price target of GBX 662.86, indicating a potential upside of 4.73%. Synthomer has a consensus price target of GBX 86.75, indicating a potential downside of 21.85%. Given Victrex's stronger consensus rating and higher probable upside, analysts plainly believe Victrex is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Victrex	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

75.5% of Victrex shares are held by institutional investors. Comparatively, 19.7% of Synthomer shares are held by institutional investors. 4.2% of Victrex shares are held by insiders. Comparatively, 5.0% of Synthomer shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Victrex beats Synthomer on 11 of the 16 factors compared between the two stocks.

How does Synthomer compare to Scapa Group?

Synthomer (LON:SYNT) and Scapa Group (LON:SCPA) are both small-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

19.7% of Synthomer shares are held by institutional investors. 5.0% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Scapa Group has a net margin of 0.00% compared to Synthomer's net margin of -9.03%. Scapa Group's return on equity of 0.00% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Scapa Group	N/A	N/A	N/A

In the previous week, Synthomer's average media sentiment score of 0.76 beat Scapa Group's score of 0.00 indicating that Synthomer is being referred to more favorably in the media.

Company	Overall Sentiment
Synthomer	Positive
Scapa Group	Neutral

Scapa Group has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Scapa Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A

Synthomer currently has a consensus price target of GBX 86.75, indicating a potential downside of 21.85%. Given Scapa Group's higher probable upside, analysts clearly believe Scapa Group is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Synthomer beats Scapa Group on 6 of the 11 factors compared between the two stocks.

How does Synthomer compare to Essentra?

Essentra (LON:ESNT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

69.5% of Essentra shares are held by institutional investors. Comparatively, 19.7% of Synthomer shares are held by institutional investors. 0.5% of Essentra shares are held by company insiders. Comparatively, 5.0% of Synthomer shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Essentra has a net margin of 0.70% compared to Synthomer's net margin of -9.03%. Essentra's return on equity of 0.79% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Essentra	0.70%	0.79%	1.74%
Synthomer	-9.03%	-16.66%	-0.28%

Essentra has a beta of 0.802, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Synthomer has a beta of 1.012, suggesting that its stock price is 1% more volatile than the broader market.

In the previous week, Essentra had 1 more articles in the media than Synthomer. MarketBeat recorded 1 mentions for Essentra and 0 mentions for Synthomer. Synthomer's average media sentiment score of 0.76 beat Essentra's score of 0.00 indicating that Synthomer is being referred to more favorably in the news media.

Company	Overall Sentiment
Essentra	Neutral
Synthomer	Positive

Essentra currently has a consensus target price of GBX 150, suggesting a potential upside of 77.10%. Synthomer has a consensus target price of GBX 86.75, suggesting a potential downside of 21.85%. Given Essentra's stronger consensus rating and higher possible upside, equities research analysts clearly believe Essentra is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Essentra	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Essentra has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Essentra	£302M	0.79	£3.50M	£0.70	121.00
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A

Summary

Essentra beats Synthomer on 12 of the 16 factors compared between the two stocks.

How does Synthomer compare to Zotefoams?

Zotefoams (LON:ZTF) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Zotefoams has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.40	£9.80M	£44.87	10.08
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A

Zotefoams has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Synthomer has a beta of 1.012, indicating that its stock price is 1% more volatile than the broader market.

Zotefoams presently has a consensus price target of GBX 605, suggesting a potential upside of 33.70%. Synthomer has a consensus price target of GBX 86.75, suggesting a potential downside of 21.85%. Given Zotefoams' stronger consensus rating and higher probable upside, equities analysts plainly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

29.6% of Zotefoams shares are owned by institutional investors. Comparatively, 19.7% of Synthomer shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 5.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -9.03%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Synthomer	-9.03%	-16.66%	-0.28%

In the previous week, Synthomer's average media sentiment score of 0.76 beat Zotefoams' score of 0.00 indicating that Synthomer is being referred to more favorably in the news media.

Company	Overall Sentiment
Zotefoams	Neutral
Synthomer	Positive

Summary

Zotefoams beats Synthomer on 12 of the 15 factors compared between the two stocks.

How does Synthomer compare to Treatt?

Synthomer (LON:SYNT) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Synthomer has a beta of 1.012, suggesting that its share price is 1% more volatile than the broader market. Comparatively, Treatt has a beta of 0.909, suggesting that its share price is 9% less volatile than the broader market.

Treatt has a net margin of 3.40% compared to Synthomer's net margin of -9.03%. Treatt's return on equity of 3.22% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-9.03%	-16.66%	-0.28%
Treatt	3.40%	3.22%	6.72%

In the previous week, Treatt had 2 more articles in the media than Synthomer. MarketBeat recorded 2 mentions for Treatt and 0 mentions for Synthomer. Synthomer's average media sentiment score of 0.76 beat Treatt's score of 0.60 indicating that Synthomer is being referred to more favorably in the media.

Company	Overall Sentiment
Synthomer	Positive
Treatt	Positive

19.7% of Synthomer shares are owned by institutional investors. Comparatively, 17.5% of Treatt shares are owned by institutional investors. 5.0% of Synthomer shares are owned by insiders. Comparatively, 4.1% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Treatt has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.74B	0.10	-£82.04M	-£96.00	N/A
Treatt	£128.29M	1.39	£11.22M	£7.22	41.83

Synthomer currently has a consensus target price of GBX 86.75, indicating a potential downside of 21.85%. Treatt has a consensus target price of GBX 248.33, indicating a potential downside of 17.77%. Given Treatt's stronger consensus rating and higher possible upside, analysts plainly believe Treatt is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Treatt beats Synthomer on 11 of the 16 factors compared between the two stocks.

Get Synthomer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SYNT vs. The Competition

Export

Metric	Synthomer	Specialty Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£181.98M	£8.89B	£4.88B	£2.80B
Dividend Yield	28.47%	3.39%	4.99%	6.18%
P/E Ratio	-1.16	15.46	23.76	366.94
Price / Sales	0.10	117.68	5,969.92	86,476.21
Price / Cash	2.28	19.25	24.28	27.85
Price / Book	0.17	3.37	9.38	7.77
Net Income	-£82.04M	£213.62M	£156.77M	£5.89B
7 Day Performance	5.71%	-0.75%	2.19%	0.76%
1 Month Performance	7.56%	0.10%	-2.28%	1.84%
1 Year Performance	-4.15%	26.21%	60.65%	73.86%

Synthomer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SYNT Synthomer	1.7993 of 5 stars	GBX 111 -3.5%	GBX 86.75 -21.8%	-0.7%	£181.98M	£1.74B	N/A	4,200
VCT Victrex	1.3457 of 5 stars	GBX 635 -1.9%	GBX 702.86 +10.7%	-20.3%	£553.24M	£296.40M	19.97	1,109	News Coverage
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ESNT Essentra	3.8122 of 5 stars	GBX 84.70 +0.8%	GBX 150 +77.1%	-14.2%	£240.48M	£302M	121.00	350	Gap Up
ZTF Zotefoams	N/A	GBX 432.83 -1.3%	GBX 605 +39.8%	+44.3%	£211.76M	£158.49M	9.65	549

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:SYNT) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synthomer (SYNT) Competitors